Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Endocrinology
Dr. Evan D. Rosen, MD
|
|
Give Review
Evan Rosen works in the field of Endocrinology. He has 1 awards "Elected Member". Evan Rosen is also a published doctor. He has 64 paper published. The most recent paper is: Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.
Publications
- Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.
- Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 Diabetes.
- IRF4 Is a Key Thermogenic Transcriptional Partner of PGC-1α.
- A Smooth Muscle-Like Origin for Beige Adipocytes.
- What we talk about when we talk about fat.
- Early B-cell Factor-1 (EBF1) Is a Key Regulator of Metabolic and Inflammatory Signaling Pathways in Mature Adipocytes.
- Charting a dynamic DNA methylation landscape of the human genome.
- Interferon regulatory factor 4 regulates Obesity-induced inflammation through regulation of adipose tissue macrophage polarization.
- Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages.
- Lessons on Conditional Gene Targeting in Mouse Adipose Tissue.
- Regulation of early adipose commitment by zfp521.
- Identifying novel transcriptional components controlling energy metabolism.
- A MINOR ROLE FOR LIPOCALIN 2 IN HIGH FAT DIET-INDUCED GLUCOSE INTOLERANCE.
- Transcriptional control of adipose Lipid handling by IRF4.
- Comparative epigenomic analysis of murine and human adipogenesis.
- Mammalian stem cells reprogramming in response to terahertz radiation.
- The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis.
- Interferon regulatory factors are transcriptional regulators of adipogenesis.
- The adipokine lipocalin 2 is regulated by Obesity and promotes insulin resistance.
- FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults.
- Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade.
- New drugs from fat bugs?
- Absence of a reductase, NCB5OR, causes insulin-deficient Diabetes.
- Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostagland...
- Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.
- Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
- The molecular control of adipogenesis, with special reference to lymphatic pathology.
- Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms.
- C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.
- Adipocyte differentiation from the inside out.
- Adipocytes as regulators of energy balance and glucose homeostasis.
- Reactive oxygen species have a causal role in multiple forms of insulin resistance.
- Energy balance: a new role for PPARalpha.
- Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
- The transcriptional basis of adipocyte development.
- Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation.
- Transcriptional regulation of adipogenesis.
- Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache.
- Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.
- PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.
- The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
- Transcriptional targets in adipocyte biology.
- PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.
- Molecular regulation of adipogenesis.
- The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.
- Characterization of transcriptional regulatory elements in the promoter region of the murine blood coagulation factor VII gene.
- Ligand-dependent synergy of Thyroid hormone and retinoid X receptors.
- Dimerization interfaces of Thyroid hormone, retinoic acid, vitamin D, and retinoid X receptors.
- Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.
- Molecular mechanisms of adipocyte differentiation.
- Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
- Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.
- Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.
- Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
- Protein-protein interactions involving erbA superfamily receptors: through the TRAPdoor.
- In utero transplantation of wild-Type fetal liver cells rescues factor X-deficient mice from fatal neonatal bleeding diatheses.
- Maintaining fetal normoglycemia prevents the increase in myometrial activity and uterine 13,14-dihydro-15-keto-prostaglandin F2 alpha production during food withdrawal...
- Development of pulmonary fibrosis in fibrinogen-deficient mice.
- The characterization of mice with a targeted combined deficiency of protein c and factor XI.
- Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.
- A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
- Nucleotide structure and characterization of the murine gene encoding the endothelial cell protein C receptor.
- Adipocyte-specific transgenic and knockout models.
Schools
University of Mi Med Sch
Brigham and Women39s Hospital
Mass General Hospital
Conditions Treated
- Acromegaly and Gigantism
- Diabetes Type 2
- Goiter
- HyperLipidemia
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1639110174 | |
| NPPES Provider LastName | ROSEN | |
| NPPES Provider FirstName | EVAN | |
| NPPES Provider ZIPCode | 022155400 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 82.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639110174 |
| Last Name Of The Provider | ROSEN |
| First Name Of The Provider | EVAN |
| View All |
Similar Doctors
|
|
Dr. Elaine W. Yu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Conlin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jean E. Mulder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Turchin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Z. Leder, MD
This Doctor is OpenDoctor Recommended.
|